• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤通过上调FOXP3(+)调节性T细胞诱导免疫抑制。

Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.

作者信息

Baumgartner Joel, Wilson Cara, Palmer Brent, Richter Don, Banerjee Anirban, McCarter Martin

机构信息

Department of Surgery, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80262, USA.

出版信息

J Surg Res. 2007 Jul;141(1):72-7. doi: 10.1016/j.jss.2007.03.053.

DOI:10.1016/j.jss.2007.03.053
PMID:17574040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2043471/
Abstract

BACKGROUND

The immune response to melanoma is rarely curative, suggesting the emergence of immunosuppression. FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses. The objective of this study was to determine if melanoma evades immune surveillance, in part, by inducing T(reg) cells.

MATERIAL AND METHODS

Peripheral blood mononuclear cells (PBMCs) were isolated and exposed to melanoma-conditioned media (MCM) or control media for 1 week. The induction of T(reg) cells in these PBMCs was determined by measuring the proportion of CD25(+)FOXP3(+) T cells in all CD4(+) T cells by flow cytometry. FOXP3 expression was determined by mean fluorescence intensity (MFI) and Western blot. Supernatant cytokines were determined by ELISA.

RESULTS

Normal PBMCs exposed to MCM revealed higher proportions of T(reg) cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02). The expression of FOXP3 in T(reg) cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media. The level of IL-10 and TGF-beta in supernatants after 6 days growth was higher in MCM than control media, but this did not reach statistical significance.

CONCLUSION

Exposure of PBMCs to melanoma results in induction of FOXP3(+) T(reg) cells.

摘要

背景

对黑色素瘤的免疫反应很少能治愈,这表明免疫抑制的出现。表达叉头框蛋白3(FOXP3)的调节性T细胞(Treg细胞)具有抑制免疫反应的功能。本研究的目的是确定黑色素瘤是否部分通过诱导Treg细胞来逃避免疫监视。

材料与方法

分离外周血单个核细胞(PBMC),并将其暴露于黑色素瘤条件培养基(MCM)或对照培养基中1周。通过流式细胞术测量所有CD4+T细胞中CD25+FOXP3+T细胞的比例,以确定这些PBMC中Treg细胞的诱导情况。通过平均荧光强度(MFI)和蛋白质免疫印迹法测定FOXP3的表达。通过酶联免疫吸附测定法测定上清液中的细胞因子。

结果

暴露于MCM的正常PBMC在6天后显示出比暴露于对照培养基的PBMC更高比例的Treg细胞(分别为3.4%和1.3%,P<0.02)。通过MFI和蛋白质免疫印迹法,暴露于MCM的PBMC中Treg细胞的FOXP3表达随时间增加,但与暴露于对照培养基的PBMC相比无显著差异。生长6天后,MCM中上清液的白细胞介素-10(IL-10)和转化生长因子-β(TGF-β)水平高于对照培养基,但未达到统计学显著性。

结论

PBMC暴露于黑色素瘤会导致FOXP3+Treg细胞的诱导。

相似文献

1
Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.黑色素瘤通过上调FOXP3(+)调节性T细胞诱导免疫抑制。
J Surg Res. 2007 Jul;141(1):72-7. doi: 10.1016/j.jss.2007.03.053.
2
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.表达白细胞介素10的调节性T细胞在没有白细胞介素10的情况下由Foxp3 +和Foxp3-前体细胞发育而来。
Nat Immunol. 2007 Sep;8(9):931-41. doi: 10.1038/ni1504. Epub 2007 Aug 12.
3
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.黑色素瘤细胞中 Foxp3 的表达可能是对免疫破坏产生抵抗的机制之一。
Cancer Immunol Immunother. 2011 Aug;60(8):1109-18. doi: 10.1007/s00262-011-1025-3. Epub 2011 May 6.
4
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.表达Foxp3的CD4+CD25(高表达)调节性T细胞在人类转移性黑色素瘤淋巴结中占比过高,并抑制浸润性T细胞的功能。
J Immunol. 2004 Jul 15;173(2):1444-53. doi: 10.4049/jimmunol.173.2.1444.
5
Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.变应性哮喘患者的CD4+CD25+调节性T细胞在体外经变应原刺激后增殖不足。
Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10.
6
Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.接受黑色素瘤抗原脉冲成熟单核细胞来源树突状细胞疫苗治疗的黑色素瘤患者外周血中的免疫调节性T细胞
J Dermatol Sci. 2009 Apr;54(1):31-7. doi: 10.1016/j.jdermsci.2008.11.007. Epub 2009 Jan 20.
7
Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.恶性疟原虫介导的人类CD25Foxp3 CD4 T细胞诱导不依赖于直接的TCR刺激,且需要白细胞介素-2、白细胞介素-10和转化生长因子β。
PLoS Pathog. 2009 Aug;5(8):e1000543. doi: 10.1371/journal.ppat.1000543. Epub 2009 Aug 14.
8
TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.转化生长因子β1(TGF-β1)在不同的CD4 + T细胞亚群中调节叉头框蛋白3(Foxp3)的表达和调节活性。
J Leukoc Biol. 2007 Aug;82(2):335-46. doi: 10.1189/jlb.1006644. Epub 2007 May 2.
9
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.CD4+Foxp3+ 调节性 T 细胞中神经纤毛蛋白 1 缺乏可抑制小鼠黑色素瘤生长。
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
10
Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio.Foxp3+ CD25+ 调节性 T 细胞浸润强烈与高级别皮肤鳞状细胞癌相关,并且与 CD8+/Foxp3+ CD25+ 比值相平衡。
Br J Dermatol. 2015 Jan;172(1):64-73. doi: 10.1111/bjd.13172. Epub 2014 Nov 30.

引用本文的文献

1
Mechanisms of Altered Immune Response in Skin Melanoma.皮肤黑色素瘤免疫反应改变的机制
Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30.
2
Anticancer effect of terpenes: focus on malignant melanoma.萜类化合物的抗癌作用:聚焦恶性黑素瘤。
Pharmacol Rep. 2023 Oct;75(5):1115-1125. doi: 10.1007/s43440-023-00512-1. Epub 2023 Jul 29.
3
The Ratio of GrzB - FoxP3 over CD3 T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma.GrzB - FoxP3与CD3 T细胞的比值作为转移性黑色素瘤患者对纳武单抗反应的潜在预测指标

本文引用的文献

1
Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.健康与自身免疫中天然存在的调节性T细胞的功能动力学。
Adv Immunol. 2006;92:119-55. doi: 10.1016/S0065-2776(06)92003-3.
2
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients.晚期胰腺癌患者外周血中Foxp3+CD4+ T细胞数量增加的临床作用。
Pancreas. 2006 Nov;33(4):386-90. doi: 10.1097/01.mpa.0000240275.68279.13.
3
Targeting tumor-related immunosuppression for cancer immunotherapy.
Cancers (Basel). 2021 May 12;13(10):2325. doi: 10.3390/cancers13102325.
4
FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation.FOXP3 在消退型黑素瘤中的表达:肿瘤表达与调节性 T 细胞上调之间的关系。
J Immunol Res. 2020 Oct 23;2020:5416843. doi: 10.1155/2020/5416843. eCollection 2020.
5
Overcoming Immune Evasion in Melanoma.克服黑色素瘤的免疫逃逸。
Int J Mol Sci. 2020 Nov 26;21(23):8984. doi: 10.3390/ijms21238984.
6
Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.调节性T细胞在预防小鼠黑素细胞痣和黑色素瘤中起重要作用。
Cancer Prev Res (Phila). 2021 Feb;14(2):165-174. doi: 10.1158/1940-6207.CAPR-20-0360. Epub 2020 Nov 4.
7
Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy.肿瘤微环境:对黑色素瘤靶向治疗和免疫治疗耐药性的影响
Cancers (Basel). 2020 Oct 6;12(10):2870. doi: 10.3390/cancers12102870.
8
Varied functions of immune checkpoints during cancer metastasis.免疫检查点在癌症转移过程中的多样化功能。
Cancer Immunol Immunother. 2021 Mar;70(3):569-588. doi: 10.1007/s00262-020-02717-2. Epub 2020 Sep 9.
9
Sex Differences in Melanoma.黑色素瘤中的性别差异
Curr Epidemiol Rep. 2019 Jun;6(2):112-118. doi: 10.1007/s40471-019-00192-7. Epub 2019 May 31.
10
Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma.现代免疫疗法中的黑色素瘤检查点抑制剂。
Int J Mol Sci. 2020 Mar 30;21(7):2367. doi: 10.3390/ijms21072367.
针对肿瘤相关免疫抑制进行癌症免疫治疗。
Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):233-7. doi: 10.2174/187153006778250019.
4
IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.白细胞介素-15和真皮成纤维细胞可诱导从人皮肤中分离出的天然调节性T细胞增殖。
Blood. 2007 Jan 1;109(1):194-202. doi: 10.1182/blood-2006-02-002873. Epub 2006 Sep 12.
5
FOXP3 controls regulatory T cell function through cooperation with NFAT.FOXP3通过与NFAT协同作用来控制调节性T细胞的功能。
Cell. 2006 Jul 28;126(2):375-87. doi: 10.1016/j.cell.2006.05.042.
6
Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.浸润生长中肿瘤的产生白细胞介素-10和转化生长因子-β的T细胞对抗肿瘤免疫的抑制作用:肿瘤环境对CD4+和CD8+调节性T细胞诱导的影响
J Immunol. 2006 Jul 15;177(2):896-904. doi: 10.4049/jimmunol.177.2.896.
7
The treatment of melanoma with an emphasis on immunotherapeutic strategies.以免疫治疗策略为重点的黑色素瘤治疗
Surg Oncol. 2006 Jul;15(1):13-24. doi: 10.1016/j.suronc.2006.05.003. Epub 2006 Jul 11.
8
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.胰腺腺癌可诱导调节性T细胞(Treg)的患病率增加。
J Immunother. 2006 Jul-Aug;29(4):416-24. doi: 10.1097/01.cji.0000205644.43735.4e.
9
FOXP3: of mice and men.FOXP3:人与小鼠的情况
Annu Rev Immunol. 2006;24:209-26. doi: 10.1146/annurev.immunol.24.021605.090547.
10
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.接受高剂量白细胞介素-2治疗的转移性黑色素瘤或肾细胞癌患者中CD4+CD25+调节性T细胞的特征分析
J Clin Oncol. 2006 Mar 1;24(7):1169-77. doi: 10.1200/JCO.2005.03.6830.